PharmaShots Weekly Snapshots (July 26 - 30, 2021)
Roche Publishes the Results of Evrysdi (risdiplam) in FIREFISH Study to Treat of Type 1 SMA at NEJM
Published: July 30, 2021 | Tags: Roche, Evrysdi, risdiplam, FIREFISH Study, Type 1 SMA, NEJM
Published: July 30, 2021 | Tags: BeiGene, Brukinsa, zanubrutinib, P-III, SEQUOIA Trial, Chronic Lymphocytic Leukemia
Published: July 30, 2021 | Tags: Alnylam, PeptiDream, Peptide-siRNA Conjugates, RNAi Therapeutics, Extrahepatic Tissues
Published: July 30, 2021 | Tags: Junshi, NMPA, Acceptance, sNDA, Toripalimab, CT, Advanced, Metastatic, Esophageal Squamous Cell Carcinoma
Published: July 30, 2021 | Tags: GSK, Nucala, mepolizumab, US, FDA, Chronic Rhinosinusitis, Nasal Polyps
Published: July 30, 2021 | Tags: Lilly, Kumquat, Novel Small Molecules, Tumor-Specific Immune Responses
Takeda's TAK-994 Receives Breakthrough Therapy Designation for the Treatment of Narcolepsy Type 1
Published: July 29, 2021 | Tags: Takeda, TAK-994, Breakthrough Therapy Designation, Narcolepsy Type
Janssen Amends its Agreement with Protagonist to Develop and Commercialize IL-23 Antagonists
Published: July 29, 2021 | Tags: Protagonist, Amendment Agreement, Janssen, IL-23 Antagonists
Published: July 29, 2021 | Tags: Viatris, Biocon, Semglee, biosimilar, Insulin Glargine, US, FDA, Approval, Diabetes
Published: July 29, 2021 | Tags: Regeneron, Sanofi, Dupixent, dupilumab, P-III, LIBERTY CUPID Clinical Program, Chronic Spontaneous Urticaria
Published: July 29, 2021 | Tags: Roche, US, FDA, Acceptance, BLA, Faricimab, Diabetic Macular Edema, Neovascular Age-Related Macular Degeneration
BD Acquires Tepha to Boost its Surgical Mesh Portfolio
Published: July 29, 2021 | Tags: BD, Tepha, Surgical Mesh Portfolio
Published: July 28, 2021 | Tags: Arena, Aristea, RIST4721, Immune-Mediated Inflammatory Diseases
Published: July 28, 2021 | Tags: BridgeBio, BMS, BBP-398, Opdivo, Advanced Solid Tumors, KRAS Mutations
Sanofi's Avalglucosidase alfa Receives CHMP's Positive Opinion for Patients with Pompe Disease
Published: July 28, 2021 | Tags: Sanofi, Avalglucosidase alfa, CHMP, Pompe Disease
AbbVie and Calico Expand its Existing Collaboration to Focus on Aging and Age-Related Diseases
Published: July 28, 2021 | Tags: AbbVie, Calico, Age-Related Diseases
Published: July 28, 2021 | Tags: PeptiDream, Takeda, Peptide Drug Conjugates, CNS Diseases
Amgen to Acquire Teneobio for ~$2.5B
Published: July 28, 2021 | Tags: Amgen, Acquire, Teneobio, ~$2.5B
AstraZeneca and Regeneron Collaborate to Research, Develop and Commercialize Therapies for Obesity
Published: July 27, 2021 | Tags: AstraZeneca, Regeneron, Develop, Commercialize, Therapies, Obesity
BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022
Published: July 27, 2021 | Tags: BioNTech, Malaria, Tuberculosis Vaccines, 2022
Published: July 27, 2021 | Tags: Adagio, Biocon, COVID-19 Ab
GSK's Shingrix Receives the US FDA's Approval to Prevent Shingles in Immunocompromised Adults
Published: July 27, 2021 | Tags: GSK, Shingrix, US, FDA, Approval, Shingles, Immunocompromised
Prothena Presents Preclinical Data of its Alzheimer's Candidates at AAIC 2021
Published: July 27, 2021 | Tags: Prothena, Preclinical Data, Alzheimer Candidates, AAIC 2021
BeiGene's Brukinsa (Zanubrutinib) Receives Health Canada's Approval for Mantle Cell Lymphoma
Published: July 27, 2021 | Tags: BeiGene, Brukinsa, Zanubrutinib, Health Canada, Approval, Mantle Cell Lymphoma
PerkinElmer to Acquire BioLegend for $5.25B
Published: July 26, 2021 | Tags: PerkinElmer, Acquire, BioLegend, $5.25B
Published: July 26, 2021 | Tags: Denali, DNL310, P-I/II, Study, Lysosomal Storage Disease Hunter Syndrome, MPS II
Published: July 26, 2021 | Tags: US, FDA, Incyte, Retifanlimab, Squamous Cell Carcinoma, Anal Canal
AbbVie Presents Results of AGN-190584 in P-III GEMINI 1 Study for Presbyopia at 2021 ASCRS
Published: July 26, 2021 | Tags: AbbVie, AGN-190584, P-III, GEMINI 1 Study, Presbyopia, 2021 ASCRS
Published: July 26, 2021 | Tags: Alexion, Ultomiris, ravulizumab, CHMP, PNH
Published: July 26, 2021 | Tags: AstraZeneca, Vaxzevria, Delta Variants, SARS-CoV-2 Virus
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com